Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

A seven-day, extended-release version of buprenorphine — a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths — is safe and effective for people with OUD ...

Buprenorphine is a medication approved for pain and opioid dependence. New findings published in The American Journal on Addictions indicate that a transmucosal dose (which dissolves in the mouth) of ...

Please provide your email address to receive an email when new articles are posted on . Patients who participated in yoga sessions alongside usual care reached withdrawal stabilization 4.4 times ...

Injectable, extended-release buprenorphine was deemed safe for patients experiencing minimal to mild opioid withdrawal (COWS scores 4-7), making the drug a viable and safe treatment option, according ...

Nausea, sweating, and diarrhea are just some of the possible symptoms of opioid withdrawal. How soon those symptoms start and how long they last can vary by person, but the general opioid withdrawal ...

Spark Biomedical is joined by the Battelle Memorial Institute and Hazelden Betty Ford Foundation to begin pioneering an AI-powered, wearable, closed-loop neurostimulation system to improve opioid ...

FORT LAUDERDALE, FL - April 15, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...